Home

EVAg

European Virus Archive - GLOBAL
  • Contact Us
  • FAQs
  • Login / Register
  • RSS
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
  • Home
  • Portal
  • The project
    • Concept & Approach
    • ABS Strategy
    • DURC issues
    • News
    • Publications
    • Newsletters
  • Partners
  • Industrials
  • Home
  • The project
  • News

News

Latest news

  • June 27, 2025

    Partners in EVORA

    EVAg
  • June 25, 2025

    EVORA: European Research Infrastructures Join Forces to Strengthen Pandemic Response and Preparedness

    EVAg
  • April 28, 2025

    Release of Complete CHIKV Coding Sequence from Réunion Island 2024 (GenBank: PV035814)

    EVAg
  • April 7, 2025

    EVA-AISBL Press Release

    EVAg
  • November 19, 2024

    EVORA Workshop Invitation: Unlock the Power of Your Research Data for Global Impact – February 6, 2025

    EVAg
  • July 26, 2024

    EVA in motion!

    EVAg
  • July 26, 2024

    What are the EVA end-users working on?

    EVAg
  • March 29, 2024

    Dual-use research of concern (DURC) issues in the life sciences

    EVAg
  • March 1, 2024

    Uncultivable collection

    EVAg
  • February 5, 2024

    Cécile...the multifaceted scientific liaison of AMU

    EVAg
  •  
  • 1 of 4
  • next ›
Hotline

EVAg Hotline

Any institution that requires guidance on the actions that should be taken for recording, reporting, investigating security breaches and to ensure the safety of all staff, can be supported by EVAg

For tropical and RG4 viruses

In the event of a major biological incident regarding tropical (exotic) viruses or Risk Group 4 viruses, contact

Bernard Nocht Institute by clicking here

For other human viruses of medical importance

The Charité University Berlin (CUB) is in charge of our hotline dedicated to other human viruses of medical importance

Contact the CUB here

For veterinary pathogens of economic importance

In case of biological events involving such pathogens contact
The Animal and Plant Health Agency here

or
+44 1932 357840

EVAg

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 871029


H2020 - grant agreement n°871029-EVA-GLOBAL
  • FAQs
  • Sitemap
  • Legal mentions
  • Newsletter
  • Contact
  • RSS
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
The EVA-GLOBAL community supports fair and equitable benefit sharing as conceived in various United Nations frameworks. The consortium is actively implementing a CBD/Nagoya Protocol compliance strategy. Learn more ...